Dr. Hariprasad G
- Last Updated On :
Dr. Hariprasad G
|
|
|||||||||
| Designation | Associate Professor | ||||||||
| This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it. | |||||||||
| Contact Number | +91-11-26594240 | ||||||||
| Educational Qualifications | M.D., Ph.D | ||||||||
| Research Interests | Biomarker discovery; Structure Based Drug Design; Medical Education | ||||||||
| Awards and Honors |
|
||||||||
| Recent Significant Publications
|
Sehrawat U, Pokhriyal R, Gupta AK, Hariprasad R, Khan I, Gupta D, Naru J, Singh SB, Mohanty AK, Vanamail P, Kumar L, Kumar S, Hariprasad G*. Comparative proteomic analysis of advanced ovarian cancer tissue to identify potential biomarkers of responders and non-responders to first line chemotherapy of carboplatin and paclitaxel. Biomarkers in Cancer (2016) 8:43-56 | ||||||||
| Khan MI, GuptaAK, KumaR, Ethayathulla AS, Kumar M, Hariprasad G*. Molecular modeling of Gly80 and Ser80 variants of human group IID phospholipase A2 and their receptor complexes: potential basis for weight loss in chronic obstructive pulmonary disease. Journal of Molecular Modeling (2016) 22:232 | |||||||||
| Hariprasad G*, Hariprasad R, Kumar L, Srinivasan A, Srujana K, Kaushik A. Apolipoprotein A1 as a potential biomarker in the ascetic fluid for the differentiation of advanced ovarian cancers. (2013) Biomarkers. 18: 532-41. | |||||||||
| Hariprasad G*, Kota D, Singh SB, Srinivasan A, Adhikary S. Delineation of the structural elements of oriental liver fluke PLA2 isoforms for potent drug designing. (2014) Indian J Clin Biochem. In Press | |||||||||
| Hariprasad G*, Srinivasan A, Singh R. Structural and phylogenetic basis for the classification of group III phospholipase A2. (2013) J Mol Model. 19: 3779-91 | |||||||||
| Hariprasad G*, Kaur P, Srinivasan A, Singh TP, Kumar M. Structural analysis of secretory phospholipase A2from Clonorchis sinensis: therapeutic implications for hepatic fibrosis. (2012) J Mol. Model. 18: 3139-3145. | |||||||||
| Hariprasad G*, Kaur P, Srinivasan A, Singh TP, Kumar M. Structural analysis of secretory phospholipase A2from Clonorchis sinensis: therapeutic implications for hepatic fibrosis. (2012) J Mol. Model. 18: 3139-3145 | |||||||||
| Hariprasad G, Kumar M, Rani K, Kaur P, Srinivasan A. (2012) Aminoglycoside induced nephrotoxicity: Molecular modeling studies of the calreticulin-gentamicin complex. J Mol. Model. 18: 2645-2652. | |||||||||
| Hariprasad G*, Kumar M, Srinivasan A, Kaur P, Singh TP, Jithesh O. (2011) Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: targeting and reversible inhibition by native peptides. Int. J Biol. Macromol. 48: 423–431. | |||||||||
| Hariprasad G*, Srinivasan A, Vedakumari Y. (2011) Electrical conductivity as a tool to detect salt in clinical proteomics samples. Indian J Clin. Biochem. 26: 82-83. | |||||||||
| Hariprasad G*, Kumar M, Kaur P, Singh TP, Kumar RP. (2010) Human group III PLA2 as a drug target: Structural analysis and inhibitor binding studies. Int. J Biol. Macromol. 47: 496-501 | |||||||||
| Hariprasad G* (2008) Rationale for student exposure to pre- and para medical sciences as part of internship. Med. Educ. 42: 645. | |||||||||
| Hariprasad G* (2008) Holistic presentation of the under graduate medical curriculum. Med. Educ. 42: 849. | |||||||||
